Insider · CIK 0001341896
Andrew J. Fromkin
Files at IMVT (Immunovant, Inc.). First filing Mar 11, 2025, latest May 29, 2026.
In brief
Andrew J. Fromkin files SEC Form 4 as director at IMVT (Immunovant, Inc.). Since Mar 11, 2025, Andrew J. Fromkin has reported 0 open-market buys worth $0 and 3 open-market sells worth $8.1M, the latest filed on May 29, 2026.
A track record needs three past buys with six months of prices behind them; Andrew J. Fromkin has 0, so none is measured yet.
The newest scored trade: sold $7.4M of IMVT on May 28, 2026, filed May 29, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 2 sells worth $8.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Immunovant, Inc. | $7.4M 221,951 shares | -75% | +138% from low-6% from high | |
| 33Weak | Immunovant, Inc. | $517k 22,249 shares | -21% | +71% from low-21% from high | |
| 6Weak | Immunovant, Inc. | $157k 8,000 shares | -8% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 28, 2026 | IMVT IMMUNOVANT, INC. | 221,951 0.11% of outstanding | $7.4M | May 28, 2026 | none |
| Dec 1, 2025 | IMVT IMMUNOVANT, INC. | 22,249 0.01% of outstanding | $537k | Dec 1, 2025 | none |
| Mar 7, 2025 | IMVT IMMUNOVANT INC | 8,000 0.00% of outstanding | $156k | Mar 7, 2025 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Common Stock | +31,668 | $4.99 | $158k | 131,400 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Common Stock | +71,492 | $7.94 | $568k | 202,892 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Common Stock | +77,181 | $8.43 | $651k | 280,073 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Common Stock | +16,260 | $14.70 | $239k | 296,333 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -11,483 | $32.64 | $375k | 284,850 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -210,468 | $33.56 | $7.1M | 74,382 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Stock Option (right to buy)derivative | -31,668 | $0.00 | $0 | 0 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Stock Option (right to buy)derivative | -71,492 | $0.00 | $0 | 0 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Stock Option (right to buy)derivative | -77,181 | $0.00 | $0 | 0 | May 29, 2026 |
| May 28, 2026 | IMVT Immunovant, Inc. | MOption exercise Stock Option (right to buy)derivative | -16,260 | $0.00 | $0 | 0 | May 29, 2026 |
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +13,880 | $0.00 | $0 | 99,732 | Apr 9, 2026 |
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,061 | $0.00 | $0 | 7,061 | Apr 9, 2026 |
| Dec 1, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -19,351 | $23.14 | $448k | 88,750 | Dec 3, 2025 |
| Dec 1, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -2,898 | $23.95 | $69k | 85,852 | Dec 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +16,188 | $0.00 | $0 | 108,101 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,600 | $0.00 | $0 | 7,600 | Apr 3, 2025 |
| Mar 7, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -6,616 | $19.52 | $129k | 93,297 | Mar 11, 2025 |
| Mar 7, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock10b5-1 | -1,384 | $19.96 | $28k | 91,913 | Mar 11, 2025 |
Questions about Andrew J. Fromkin
Answered from the filings on this page, as of the latest one.
Is Andrew J. Fromkin buying or selling?
In the last 12 months Andrew J. Fromkin reported 0 open-market buys worth $0 and 2 open-market sells worth $8.0M on SEC Form 4; the latest was sold $7.4M of IMVT on May 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Andrew J. Fromkin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew J. Fromkin has 0.
Where does Andrew J. Fromkin file Form 4?
Andrew J. Fromkin has filed Form 4 at IMVT (Immunovant, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.